Speakers

Dr Henry Chiou (touring Australia only)

Senior Product Manager
Protein Expression, Life Technologies

Previously an R&D group leader for transfection, Henry directed the development of reagents such as Lipofectamine® LTX, Lipofectamine® RNAi. Now, as Senior Product Manager, Henry has led the development and launch of the new Expi293™ transient expression system. Prior to joining Life Technologies, Henry worked in small to mid-sized biotech companies on non-viral delivery systems for gene therapy.

Dr Shou Wong (touring Australia and New Zealand)

Associate Director of Business Development
Synthetic Biology, Life Technologies

In 2000, Shou joined Novagen, as Group Leader for Mammalian Expression System. From 2000 to 2012, Shou worked at Merck KGaA where he held the position of Director of Technology Scouting making him responsible for identifying innovative early-stage platform technologies applicable to Pharmaceutical industry as well as Life Science and Chemical industries.

To register & join in your state, please complete and submit the form.